Exact Mass: 363.1583

Leg5Ac7Ala

C14H25N3O8 (363.1642)

(2S)-1-[(2S)-3-(4H-Imidazol-4-yl)-2-[[(2S)-5-oxopyrrolidine-2-carbonyl]amino]propanoyl]pyrrolidine-2-carboxylic acid

C16H21N5O5 (363.1543)

N-((Tetrahydro-5-oxo-2-furanyl)carbonyl)-L-histidyl-L-prolinamide

C16H21N5O5 (363.1543)

Pglu-his-pro

C16H21N5O5 (363.1543)

D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones Thyrotropin-Releasing Hormone (TRH), Free Acid (TRH-OH) is a physiological metabolite of Thyrotropin-Releasing Hormone.

Amphorogynine C

C19H25NO6 (363.1682)

Kealiinine B

C21H21N3O3 (363.1583)

(-)-Spirotriprostatin

C21H21N3O3 (363.1583)

Stephuline

C19H25NO6 (363.1682)

AUSTAMIDE

C21H21N3O3 (363.1583)

Longaninine

C19H25NO6 (363.1682)

Dechlorodauricumine

C19H25NO6 (363.1682)

Almazole A

C21H21N3O3 (363.1583)

PGlu-3-methyl-His-Pro-NH2

C16H21N5O5 (363.1543)

Antibiotic SF 2339

C14H25N3O8 (363.1642)

2alpha-hydroxylenticellarine

C19H25NO6 (363.1682)

(15E)-12beta-acetoxy-18-nor-senecionane-11,16-dione|Crotastriatin|crotastriatine|O-acetyl-nilgirine

C19H25NO6 (363.1682)

Nauclechine

C21H21N3O3 (363.1583)

Lyadine

C21H21N3O3 (363.1583)

alpha-Naucleonidine

C21H21N3O3 (363.1583)

C19H25NO6

C19H25NO6 (363.1682)

Nauclefoline +

C21H21N3O3 (363.1583)

crotavitelin

C19H25NO6 (363.1682)

O-Methylhernandine

C19H25NO6 (363.1682)

Cadamine

C21H21N3O3 (363.1583)

Antibiotic RP 35391

C15H21N7O4 (363.1655)

Ala His His

C15H21N7O4 (363.1655)

Lys Asn Cys

C13H25N5O5S (363.1576)

His Ala His

C15H21N7O4 (363.1655)

Cys Lys Asn

C13H25N5O5S (363.1576)

His His Ala

C15H21N7O4 (363.1655)

C21H21N3O3_8,8-Dimethyl-5a,6-dihydro-3H,5H,8H-spiro[indole-2,7-pyrrolo[1,2:4,5]pyrazino[1,2-a]azepine]-3,5,12(1H,2H)-trione

C21H21N3O3 (363.1583)

Cys Gly Gly Lys

C13H25N5O5S (363.1576)

Cys Gly Lys Gly

C13H25N5O5S (363.1576)

Cys Lys Gly Gly

C13H25N5O5S (363.1576)

Gly Cys Gly Lys

C13H25N5O5S (363.1576)

Gly Cys Lys Gly

C13H25N5O5S (363.1576)

Gly Gly Cys Lys

C13H25N5O5S (363.1576)

Gly Gly Lys Cys

C13H25N5O5S (363.1576)

Gly Lys Cys Gly

C13H25N5O5S (363.1576)

Gly Lys Gly Cys

C13H25N5O5S (363.1576)

Lys Cys Gly Gly

C13H25N5O5S (363.1576)

Cys Asn Lys

C13H25N5O5S1 (363.1576)

Lys Gly Cys Gly

C13H25N5O5S (363.1576)

Lys Gly Gly Cys

C13H25N5O5S (363.1576)

Asn Lys Cys

C13H25N5O5S1 (363.1576)

Lys Cys Asn

C13H25N5O5S1 (363.1576)

Asn Cys Lys

C13H25N5O5S1 (363.1576)

Lys Asn Cys

C13H25N5O5S1 (363.1576)

Cys Lys Asn

C13H25N5O5S1 (363.1576)

Dizatrifone

C21H21N3O3 (363.1583)

3-HYDROXY-2,3-DIMETHYLBUTAN-2-YL HYDROGEN (3-((1,3-DIOXOISOINDOLIN-2-YL)METHYL)PHENYL)BORONATE

C21H22BNO4 (363.1642)

(2-PHTALIMIDOMETHYLPHENYL)BORONIC ACID, PINACOL ESTER

C21H22BNO4 (363.1642)

Urea, N-[2-[(3-cyano-8-methyl-2-quinolinyl)amino]ethyl]-N-(4-fluorophenyl)- (9CI)

C20H18FN5O (363.1495)

Urea, N-[2-[(3-cyano-8-methyl-2-quinolinyl)amino]ethyl]-N-(2-fluorophenyl)- (9CI)

C20H18FN5O (363.1495)

[2-(dimethylamino)-2-methylpropyl] 2-hydroxy-2,2-diphenylacetate,hydrochloride

C20H26ClNO3 (363.1601)

(4-PHTHALIMIDOMETHYLPHENYL)BORONIC ACID, PINACOL ESTER

C21H22BNO4 (363.1642)

erythro-N-[(Phenylmethoxy)carbonyl]-3-allyl-L-aspartic acid 1-tert-butyl ester

C19H25NO6 (363.1682)

pyridine, 1-oxide-4-ethenyl-, homopolymer

C21H21N3O3 (363.1583)

Ozenoxacin

C21H21N3O3 (363.1583)

D - Dermatologicals > D06 - Antibiotics and chemotherapeutics for dermatological use > D06A - Antibiotics for topical use C254 - Anti-Infective Agent > C258 - Antibiotic > C795 - Quinolone Antibiotic D000970 - Antineoplastic Agents > D059003 - Topoisomerase Inhibitors D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents D004791 - Enzyme Inhibitors

(15E)-12β-Acetoxy-18-norsenecionan-11,16-dione

C19H25NO6 (363.1682)

adafenoxate

C20H26ClNO3 (363.1601)

4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)-1-tosyl-1,2,3,6-tetrahydropyridine

C18H26BNO4S (363.1676)

Benactyzine hydrochloride

C20H26ClNO3 (363.1601)

2-[4-(1-adamantyl)-N-methylsulfonylanilino]acetic acid

C19H25NO4S (363.1504)

Protuboxepin B

C21H21N3O3 (363.1583)

An organic heterotricyclic compound that is 10,11-dihydro-6H-oxepino[2,3-d]pyrazino[1,2-a]pyrimidine-6,9(8H)-dione substituted by a benzyl group at position 8 and an isopropyl group at position 11. It has been isolated from Aspergillus species.

2-[(4-amino-5-cyclohexyl-1,2,4-triazol-3-yl)thio]-N-(3-fluoro-4-methylphenyl)acetamide

C17H22FN5OS (363.1529)

(5E,7S)-2-amino-7-(4-fluoro-2-pyridin-3-ylphenyl)-4-methyl-7,8-dihydroquinazolin-5(6H)-one oxime

C20H18FN5O (363.1495)

(2S)-1-[(2S)-3-(4H-Imidazol-4-yl)-2-[[(2S)-5-oxopyrrolidine-2-carbonyl]amino]propanoyl]pyrrolidine-2-carboxylic acid

C16H21N5O5 (363.1543)

6-(1,3-benzodioxol-5-yl)-N-(3-oxanylmethyl)-4-quinazolinamine

C21H21N3O3 (363.1583)

(9S,11R)-12,12-dimethylspiro[1,7-diazatricyclo[7.5.0.03,7]tetradeca-3,13-diene-11,2-1H-indole]-2,3,8-trione

C21H21N3O3 (363.1583)

Ala-His-His

C15H21N7O4 (363.1655)

2-[[2-[1-(2-methoxyethyl)-2,5-dimethyl-3-pyrrolyl]-2-oxoethyl]thio]-6-propyl-1H-pyrimidin-4-one

C18H25N3O3S (363.1617)

(5Z)-4-methoxy-3-methyl-5-[(1R,9R,10R,11R,12S)-12-methyl-5-oxido-14,15-dioxa-5-azoniatetracyclo[7.5.1.01,11.05,10]pentadecan-13-ylidene]furan-2-one

C19H25NO6 (363.1682)

6-(1,3-benzodioxol-5-yl)-N-(2-oxanylmethyl)-4-quinazolinamine

C21H21N3O3 (363.1583)

2-[(3R,4S)-3-[[5-(methoxymethyl)-1,2-oxazol-3-yl]methyl]piperidin-4-yl]-N-(thiophen-2-ylmethyl)acetamide

C18H25N3O3S (363.1617)

His-Ala-His

C15H21N7O4 (363.1655)

[(1-amino-2-naphthalen-1-ylethylidene)amino] N-(2-ethoxyphenyl)carbamate

C21H21N3O3 (363.1583)

Lys-Cys-Asn

C13H25N5O5S (363.1576)

Lys-Asn-Cys

C13H25N5O5S (363.1576)

Asn-Cys-Lys

C13H25N5O5S (363.1576)

Asn-Lys-Cys

C13H25N5O5S (363.1576)

Cys-Asn-Lys

C13H25N5O5S (363.1576)

Cys-Lys-Asn

C13H25N5O5S (363.1576)

His-His-Ala

C15H21N7O4 (363.1655)

stemocurtisine N-oxide

C19H25NO6 (363.1682)

A natural product found in Stemona curtisii.

E1231

C21H21N3O3 (363.1583)

E1231 is an orally active activator of Sirtuin 1 (SIRT1) (EC50=0.83 μM), to modulate cholesterol and lipid metabolism. E1231 interactes with SIRT1 (KD=9.61 μM) and deacetylated liver X receptor-alpha (LXRα), and increases ATP-binding cassette transporter A1 (ABCA1) expression. E1231 also reduces atherosclerotic plaque development in ApoE-/- mice model. E1231 can be used for research in cholesterol and lipid disorder-related diseases[1]. E1231 is an orally active activator of Sirtuin 1 (SIRT1) (EC50=0.83 μM), to modulate cholesterol and lipid metabolism. E1231 interactes with SIRT1 (KD=9.61 μM) and deacetylated liver X receptor-alpha (LXRα), and increases ATP-binding cassette transporter A1 (ABCA1) expression. E1231 also reduces atherosclerotic plaque development in ApoE-/- mice model. E1231 can be used for research in cholesterol and lipid disorder-related diseases[1].

2-hydroxy-6'-(2-methylprop-1-en-1-yl)-1',7'-diazaspiro[indole-3,5'-tricyclo[7.3.0.0³,⁷]dodecan]-3'-ene-2',8'-dione

C21H21N3O3 (363.1583)

5-hydroxy-6-[(4-hydroxyphenyl)methyl]-3-(1h-indol-3-ylmethyl)-1-methyl-3,6-dihydropyrazin-2-one

C21H21N3O3 (363.1583)

methyl 4-hydroxy-3-methoxy-14-(2-methoxy-2-oxoethylidene)-9-azatetracyclo[7.5.0.0¹,⁶.0¹¹,¹³]tetradec-5-ene-13-carboxylate

C19H25NO6 (363.1682)

1-epidechloroacutumine

C19H25NO6 (363.1682)

{"Ingredient_id": "HBIN002511","Ingredient_name": "1-epidechloroacutumine","Alias": "NA","Ingredient_formula": "C19H25NO6","Ingredient_Smile": "CN1CCC23C1(CCC24C(C(=CC4=O)OC)O)C(=C(C(=O)C3)OC)OC","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "6885","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}

(1s,1's,5r,6's)-5-hydroxy-2',3',4-trimethoxy-10'-methyl-10'-azaspiro[cyclopentane-1,7'-tricyclo[4.3.3.0¹,⁶]dodecane]-2',3-diene-2,4'-dione

C19H25NO6 (363.1682)

(4s,7r)-7-benzyl-6-hydroxy-4-isopropyl-15-oxa-2,5,8-triazatricyclo[8.5.0.0³,⁸]pentadeca-1(10),2,5,11,13-pentaen-9-one

C21H21N3O3 (363.1583)

methyl 14-(hydroxymethyl)-3,13,17-triazapentacyclo[11.8.0.0²,¹⁰.0⁴,⁹.0¹⁵,²⁰]henicosa-2(10),4,6,8,15(20),16,18-heptaene-19-carboxylate

C21H21N3O3 (363.1583)

methyl (1s,6s,7ar)-6-{[3-(4-hydroxy-3-methoxyphenyl)propanoyl]oxy}-hexahydro-1h-pyrrolizine-1-carboxylate

C19H25NO6 (363.1682)

(3s,6's,9's)-2-hydroxy-6'-(2-methylprop-1-en-1-yl)-1',7'-diazaspiro[indole-3,5'-tricyclo[7.3.0.0³,⁷]dodecan]-3'-ene-2',8'-dione

C21H21N3O3 (363.1583)

(9's)-12',12'-dimethyl-1h-1',7'-diazaspiro[indole-2,11'-tricyclo[7.5.0.0³,⁷]tetradecane]-3',13'-diene-2',3,8'-trione

C21H21N3O3 (363.1583)

12',12'-dimethyl-1h-1',7'-diazaspiro[indole-2,11'-tricyclo[7.5.0.0³,⁷]tetradecane]-3',13'-diene-2',3,8'-trione

C21H21N3O3 (363.1583)

(8s,11r,12s)-4,11-dimethoxy-17-methyl-18-oxa-17-azapentacyclo[8.4.3.1⁸,¹¹.0¹,¹⁰.0²,⁷]octadeca-2,4,6-triene-3,12,13-triol

C19H25NO6 (363.1682)

methyl 6-{[3-(4-hydroxy-3-methoxyphenyl)propanoyl]oxy}-hexahydro-1h-pyrrolizine-1-carboxylate

C19H25NO6 (363.1682)

methyl (1s,3r,4s,11s,13s,14e)-4-hydroxy-3-methoxy-14-(2-methoxy-2-oxoethylidene)-9-azatetracyclo[7.5.0.0¹,⁶.0¹¹,¹³]tetradec-5-ene-13-carboxylate

C19H25NO6 (363.1682)

(2s,9's)-12',12'-dimethyl-1h-1',7'-diazaspiro[indole-2,11'-tricyclo[7.5.0.0³,⁷]tetradecane]-3',13'-diene-2',3,8'-trione

C21H21N3O3 (363.1583)

(1s,8s,10s,11r,12s,13s)-4,11,12-trimethoxy-18-oxa-17-azapentacyclo[8.4.3.1⁸,¹¹.0¹,¹⁰.0²,⁷]octadeca-2,4,6-triene-3,13-diol

C19H25NO6 (363.1682)

6,7-dimethoxy-4-(4-methoxyphenyl)-1-methyl-3h-naphtho[2,3-d]imidazol-2-imine

C21H21N3O3 (363.1583)

(1r,1's,5r,6's)-5-hydroxy-2',3',4-trimethoxy-10'-methyl-10'-azaspiro[cyclopentane-1,7'-tricyclo[4.3.3.0¹,⁶]dodecane]-2',3-diene-2,4'-dione

C19H25NO6 (363.1682)

n-(2-{2-[1-(dimethylamino)-2-phenylethyl]-1,3-oxazole-5-carbonyl}phenyl)carboximidic acid

C21H21N3O3 (363.1583)

7-benzyl-6-hydroxy-4-isopropyl-15-oxa-2,5,8-triazatricyclo[8.5.0.0³,⁸]pentadeca-1(10),2,5,11,13-pentaen-9-one

C21H21N3O3 (363.1583)

(1s,1's,5s,6's)-5-hydroxy-2',3',4-trimethoxy-10'-methyl-10'-azaspiro[cyclopentane-1,7'-tricyclo[4.3.3.0¹,⁶]dodecane]-2',3-diene-2,4'-dione

C19H25NO6 (363.1682)

(1r,9s,10r,11r,12s)-13-[(2z)-3-methoxy-4-methyl-5-oxofuran-2-ylidene]-12-methyl-14,15-dioxa-5-azatetracyclo[7.5.1.0¹,¹¹.0⁵,¹⁰]pentadecan-5-ium-5-olate

C19H25NO6 (363.1682)

methyl (1r,6r,7ar)-6-{[3-(4-hydroxy-3-methoxyphenyl)propanoyl]oxy}-hexahydro-1h-pyrrolizine-1-carboxylate

C19H25NO6 (363.1682)

(3s,6s)-5-hydroxy-6-[(4-hydroxyphenyl)methyl]-3-(1h-indol-3-ylmethyl)-1-methyl-3,6-dihydropyrazin-2-one

C21H21N3O3 (363.1583)

methyl (1r,6s,7ar)-6-{[3-(4-hydroxy-3-methoxyphenyl)propanoyl]oxy}-hexahydro-1h-pyrrolizine-1-carboxylate

C19H25NO6 (363.1682)

(1r,4z,7r)-4-ethylidene-7-hydroxy-7,14-dimethyl-6-methylidene-2,9-dioxa-14-azabicyclo[9.5.1]heptadec-11-ene-3,8,17-trione

C19H25NO6 (363.1682)

5-hydroxy-2',3',4-trimethoxy-10'-methyl-10'-azaspiro[cyclopentane-1,7'-tricyclo[4.3.3.0¹,⁶]dodecane]-2',3-diene-2,4'-dione

C19H25NO6 (363.1682)

(1r,2r,4s,5r,7r,12r,15s,23r)-4-amino-18-methoxy-6-oxa-8,16-diazaoctacyclo[10.10.1.0¹,¹⁵.0²,⁷.0⁴,¹⁵.0⁵,¹².0⁸,²³.0¹⁷,²²]tricosa-10,17(22),18,20-tetraen-3-one

C21H21N3O3 (363.1583)

(1r,1's,5s,6's)-5-hydroxy-2',3',4-trimethoxy-10'-methyl-10'-azaspiro[cyclopentane-1,7'-tricyclo[4.3.3.0¹,⁶]dodecane]-2',3-diene-2,4'-dione

C19H25NO6 (363.1682)

4,12-dimethoxy-17-methyl-18-oxa-17-azapentacyclo[8.4.3.1⁸,¹¹.0¹,¹⁰.0²,⁷]octadeca-2,4,6-triene-3,11,13-triol

C19H25NO6 (363.1682)